To understand regulation of lipogenesis, we have examined the SBP-1/SREBP transcription factors necessary for fatty acid, phospholipid and cholesterol biosynthetic gene expression and lipid accumulation in vivo. Inactive SREBPs reside cytoplasmically in the ER and are activated by transit to the Golgi, where proteases release transcriptionally active forms to the nucleus. We have found a new set of SBP target genes in the 1-carbon cycle (1CC), including
sams-1, an enzyme which produces s-adenosylmethionine (SAMe), the major methyl donor. We also found a feedback loop increasing SBP-1-dependent transcription and lipogenesis in C. elegans, murine liver and human cells when SAMe is limited. Deficiencies folate or other 1C metabolites predispose human fatty liver disease; thus, our studies linking SAMe production to SBP-1-dependent lipogenesis in C. elegans are likely relevant to metabolic disorders common in Western populations.
sbp-1(RNAi) animals are lean and several SBP-1 targets, such as
fat-7 are also required for lipogenesis. However,
sams-1(RNAi) animals have increased lipid accumulation and lipogenic gene expression which depend on
sbp-1, suggesting a feedback loop activating SBP-1 when SAMe is limiting. Metabolomic profiling after
sams-1 RNAi revealed defects in phosphatidylcholine (PC) biosynthesis, which can require multiple methylation steps. Genetic ablation of PC biosynthesis coupled with dietary rescue experiments show that SBP-1 activity is sensitive to PC levels. We also found that murine liver or human cells with diminished SAMe or PC synthesis had increases in lipogenesis and SREBP-1 activity. Because PC is a major membrane component, we reasoned that SBP-1 activation was mechanistically linked to ER or Golgi function. We found that ER stress responses are strongly activated after
sams-1 RNAi, but are not contributors to SBP-1 activation. However, Golgi markers were disrupted. Therefore we examined localization of Golgi-resident, SREBP-activating proteases in human cells and found that limiting SAMe or PC caused these proteases to relocalize to the ER, allowing processing of SREBP-1 and activation. Our observations show SBP-1/SREBP-1 may be over activated when SAMe and PC are low and may also reveal how methyl-deficient diets contribute to human fatty liver disease.